• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL CANADA, INC. 27MM TRIFECTA VALVE IDE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL CANADA, INC. 27MM TRIFECTA VALVE IDE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-27A-IDE
Device Problem Missing Information (4053)
Patient Problems Aortic Insufficiency (1715); Edema (1820); High Blood Pressure/ Hypertension (1908); No Information (3190)
Event Date 11/04/2018
Event Type  Injury  
Event Description
On (b)(6) 2008, a 27mm trifecta valve was implanted as part of the us ide study.On (b)(6) 2018, structural dysfunction was reported in the 10-year old valve.On (b)(6) 2018, a valve-in-valve procedure was completed with an unknown valve.The patient is reported stable.Additional information has been requested.(clinical study patient id: (b)(6)).
 
Manufacturer Narrative
Events of aortic insufficiency with pulmonary hypertension were reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported incident could not be conclusively determined, however, information from the field indicated that the 27mm trifecta valve had been implanted for 10 years.
 
Event Description
On (b)(6) 2008, a 27mm trifecta valve was implanted as part of the us ide study.Concomitantly, a double coronary artery bypass and primary closure of patent foramen ovale was completed.On (b)(6) 2018, the patient presented with shortness of breath and peripheral edema.Echo observed normal left ventricular function with an ejection fraction of 58%, and severe aortic insufficiency with pulmonary hypertension.Blood cultures showed no bacterial growth.The patient was treated with antibiotics for six weeks.On (b)(6) 2018, a valve-in-valve procedure was completed within the 10-year-old 27mm trifecta valve with a 26mm edwards sapien 3.The patient is reported stable.(clinical study patient id: (b)(6)).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
27MM TRIFECTA VALVE IDE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL CANADA, INC.
2550 blvd. vanier
st. hyacinthe J2S 6 L7
CA  J2S 6L7
MDR Report Key8098026
MDR Text Key128180861
Report Number8020430-2018-00023
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/21/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/17/2009
Device Model NumberTF-27A-IDE
Device Catalogue NumberTF-27A-IDE
Device Lot Number0002661383
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/20/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-